COVID-19 has exacerbated the mental health crisis in America—particularly for communities of color and the most vulnerable patients. In the latest episode of the I AM BIO Podcast, we hear from an innovative biotech CEO about what we can do now and long term to ensure access to mental health care.
The case for social distancing is clear—but we’re paying a steep price for it in terms of mental health, says BIO President and CEO Dr. Michelle McMurry-Heath in the latest episode of the I AM BIO Podcast.
Just look at the numbers: 1 in 10 Americans had seriously considered suicide in the previous 30 days, according to a CDC survey in June, and 4 in 10 are coping with addiction, mental health challenges, or both.
Why is this happening? “The very conditions that we're living through right now—and think about them in a certain order: isolation, fear, loss of loved ones, economic hardship—these are the stressors that contribute to mental illness,” explained Richard Pops, Chairman and CEO of Alkermes, which develops long-lasting injectables to treat alcohol and opioid dependence and serious mental illness.
The pandemic has been especially difficult for people with opioid dependency. “Patients are having trouble getting in front of caregivers,” he continued. “It’s an acute moment and I’m quite concerned about a resurgence of opioid overdose deaths.”
And both the COVID-19 crisis and the mental health crisis are exacerbated by racial disparities in health care. “The social determinants of health are so critically important and get amplified.”
But: “The good news is that people are becoming aware of it right now,” he added. Regulations have also been eased to facilitate telemedicine and telepsychiatry as well as the use of digital technologies in the drug-development process, which could improve the standard of care and R&D long term.
“I’m going to continue to believe that we will ultimately triumph over COVID,” Pops concluded. “But what we want to have then is actually a treatment system that learned those lessons and is even better for patients.”
Listen to the whole thing to learn more about what Alkermes is developing, how digital tech can help get new medicines to patients, and why racial disparities in health care have exacerbated both crises.
Listen at www.bio.org/podcast or your favorite podcast platform, including Apple, Google, or Spotify.
Learn more about the BIOEquality Agenda and how the industry is coming together to increase access to medicines for vulnerable communities.
More Health Care News:
Reuters: Fauci says rushing out a vaccine could jeopardize testing of others
“One of the potential dangers if you prematurely let a vaccine out is that it would make it difficult, if not impossible, for the other vaccines to enroll people in their trial,” said Dr. Anthony Fauci.